title: Guillain-Barré syndrome.
abstract: Guillain-Barré syndrome and its clinical variants are a group of rapidly progressing, potentially debilitating neurologic disorders that may have significant morbidity/mortality if left unrecognized or untreated. The most common symptoms include ascending limb weakness and paralysis, which may progress to respiratory failure. Diagnosis is made clinically with laboratory testing. Several treatment options exist, including plasma exchange and intravenous immunoglobulin administration. Most cases may resolve without sequelae, but those that do not may leave behind significant persistent debility.
authors.affiliation: Department of Medical Education, Midtown Medical Center, Columbus Regional Healthcare, 1900 10th Avenue, Suite 100, Columbus, GA 31901, USA. Electronic address: vibhuti.ansar@columbusregional.com.
authors.forename: Vibhuti
authors.initials: V
authors.lastname: Ansar
authors.affiliation: 2300-A Manchester Expressway, Suite 201, Columbus, GA 31903, USA.
authors.forename: Nojan
authors.initials: N
authors.lastname: Valadi
mesh_terms: D020275:Guillain-Barre Syndrome / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D010951:Plasma Exchange; D011320:Primary Health Care / Q000379:methods*; D012307:Risk Factors
chemical_list: D016756:Immunoglobulins, Intravenous
keywords: Acute inflammatory demyelinating polyradiculoneuropathy (AIDP); Acute motor axonal neuropathy; Demyelinating syndrome; Guillain-Barré syndrome; Miller Fisher syndrome